1. Reply
   Young‐Sun Lee et al, 2019, Hepatology CrossRef
2. Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis
   David Sooik Kim et al, 2019, Digestive Diseases and Sciences CrossRef
3. The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study
   Lei Wang et al, 2021, Journal of Gastrointestinal Surgery CrossRef
4. Barcelona Clinic Liver Cancer (BCLC) Staging: Does It Cover All Our Expectation
   Abdullah Sonsuz, 2017, Journal of Gastrointestinal Cancer CrossRef
5. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21
   Congxin Wei et al, 2018, Biomedicine & Pharmacotherapy CrossRef
6. CT radiomics combined with clinical variables for predicting the overall survival of hepatocellular carcinoma patients after hepatectomy
   Ying Liu et al, 2022, Translational Oncology CrossRef
7. Microwave Ablation in Intermediate Hepatocellular Carcinoma in Cirrhosis: An Italian Multicenter Prospective Study
   Antonio Giorgio et al, 2018, Journal of Clinical and Translational Hepatology CrossRef
8. Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
   Qunfang Zhou et al, 2020, Frontiers in Oncology CrossRef
9. Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm
   Saneya Pandrowala et al, 2023, Langenbeck's Archives of Surgery CrossRef
10. A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular carcinoma progression through stabilizing HHIP mRNA
    Changwen Bo et al, 2019, Biochemical and Biophysical Research Communications CrossRef
11. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients
    Zeyu Wang et al, 2020, BioMed Research International CrossRef
12. Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma
    Gianluca Cassese et al, 2022, Cancers CrossRef
13. Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma
    Biao Yang et al, 2018, Hepatology International CrossRef
14. Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo Pathway
    Haina Wang et al, 2021, Frontiers in Pharmacology CrossRef
15. Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery
    Ji Young Lim et al, 2020, Journal of Liver Cancer CrossRef
16. Hepatic resection compared to chemoembolization in intermediate‐ to advanced‐stage hepatocellular carcinoma: A meta‐analysis of high‐quality studies
    Myung Han Hyun et al, 2018, Hepatology CrossRef
17. Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?
    Bernardo Stefanini et al, 2024, Journal of Liver Cancer CrossRef
18. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1
    Jianfei Tu et al, 2019, Biomedicine & Pharmacotherapy CrossRef